Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 1;321(4):F494-F504.
doi: 10.1152/ajprenal.00679.2020. Epub 2021 Aug 16.

Renal mass reduction increases the response to exogenous insulin independent of acid-base status or plasma insulin levels in rats

Affiliations

Renal mass reduction increases the response to exogenous insulin independent of acid-base status or plasma insulin levels in rats

Elinor C Mannon et al. Am J Physiol Renal Physiol. .

Abstract

Impairments in insulin sensitivity can occur in patients with chronic kidney disease (CKD). Correction of metabolic acidosis has been associated with improved insulin sensitivity in CKD, suggesting that metabolic acidosis may directly promote insulin resistance. Despite this, the effect of acid or alkali loading on insulin sensitivity in a rodent model of CKD (remnant kidney) has not been directly investigated. Such studies could better define the relationship between blood pH and insulin sensitivity. We hypothesized that in remnant kidney rats, acid or alkali loading would promote loss of pH homeostasis and consequently decrease insulin sensitivity. To test this hypothesis, we determined the impact of alkali (2 wk) or acid (5-7 days) loading on plasma electrolytes, acid-base balance, and insulin sensitivity in either sham control rats, 2/3 nephrectomized rats, or 5/6 nephrectomized rats. Rats with 5/6 nephrectomy had the greatest response to insulin followed by rats with 2/3 nephrectomy and sham control rats. We found that treatment with 0.1 M sodium bicarbonate solution in drinking water had no effect on insulin sensitivity. Acid loading with 0.1 M ammonium chloride resulted in significant reductions in pH and plasma bicarbonate. However, acidosis did not significantly impair insulin sensitivity. Similar effects were observed in Zucker obese rats with 5/6 nephrectomy. The effect of renal mass reduction on insulin sensitivity could not be explained by reduced insulin clearance or increased plasma insulin levels. We found that renal mass reduction alone increases sensitivity to exogenous insulin in rats and that this is not acutely reversed by the development of acidosis.NEW & NOTEWORTHY Impairments in insulin sensitivity can occur in patients with chronic kidney disease, and previous work has suggested that metabolic acidosis may be the underlying cause. Our study investigated the effect of acid or alkali loading on insulin sensitivity in a rodent model of chronic kidney disease. We found that renal mass reduction increases the blood glucose response to insulin and that this is not acutely reversed by the development of acidosis.

Keywords: Zucker obese rat; blood glucose; chronic kidney disease; insulin resistance; metabolic acidosis.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Relationship between creatinine clearance (CrCl) and the change in pH (ΔpH) and HCO3HCO3) following alkali and acid loading in remnant kidney rats. A: relationship between CrCl and ΔpH following 2 wk of treatment with 0.1 M NaHCO3 in remnant kidney rats. y-Axis, ΔpH following treatment with 0.1 M NaHCO3; x-axis, CrCl (mL/min). Individual values are shown. n =11 animals. B: relationship between CrCl and ΔHCO3 (mmol/L) following 2 wk of treatment with 0.1 M NaHCO3 in remnant kidney rats. y-Axis, ΔHCO3 following treatment with 0.1 M NaHCO3; x-axis, CrCl (mL/min). Individual values are shown. n =11 animals. C: relationship between CrCl and ΔpH following 5–7 days of treatment with 0.1 M NH4Cl in remnant kidney rats. y-Axis, ΔpH following treatment with 0.1 M NH4Cl; x-axis, CrCl (mL/min). Individual values are shown. n =19 animals. D: relationship between CrCl and ΔHCO3 (mmol/L) following 5–7 days of treatment with 0.1 M NH4Cl in remnant kidney rats. y-Axis, ΔHCO3 following treatment with 0.1 M NH4Cl; x-axis, CrCl (mL/min). Individual values are shown. n =19 animals. P values are the results of Deming (model II) linear regression. r indicates Pearson’s correlation. *P < 0.05 was considered significant.
Figure 2.
Figure 2.
Insulin sensitivity and release following treatment with either NaHCO3 or NaCl. A: blood glucose response to insulin (0.75 U/kg) following 2 wk of either 0.1 M NaHCO3 or 0.1 M NaCl. y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals/group. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. B: inverse area under the curve (AUC) analysis for the blood glucose response to insulin between NaHCO3 or NaCl treatment. y-Axis, AUC; x-axis, treatment groups. Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals/group. P values are the results of an unpaired Student’s t test. *P < 0.05 was considered significant. C: plasma insulin levels during the insulin tolerance test following NaHCO3 or NaCl treatment. y-Axis, plasma insulin (ng/mL); x-axis, time after insulin injection (min). Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals per group. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. D: blood glucose response to glucose (1 g/kg) following 2 wk of either 0.1 M NaHCO3 or 0.1 M NaCl. y-Axis, blood glucose (mg/dL); x-axis, time after glucose gavage (min). Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals/group. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. E: AUC analysis for the blood glucose response to insulin between NaHCO3 or NaCl treatment. y-Axis, AUC; x-axis, treatment groups. Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals/group. P values are the results of an unpaired Student’s t test. *P < 0.05 was considered significant. F: plasma insulin levels during the glucose tolerance test following NaHCO3 or NaCl treatment. y-Axis, plasma insulin (ng/mL); x-axis, time after glucose gavage (min). Data were merged from the appropriate treatment phase and are means ± SE; n =11 animals/group. P values are the results of two-way ANOVA. *P < 0.05 was considered significant.
Figure 3.
Figure 3.
Insulin sensitivity and release following treatment with NH4Cl. A: the blood glucose response to insulin (0.75 U/kg) at baseline and following 5−7 days of 0.1 M NH4Cl. y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data are means ± SE; n =15 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. B: inverse area under the curve (AUC) analysis for the blood glucose response to insulin. y-Axis, AUC; x-axis, testing time points (baseline and following NH4Cl treatment). Data are means ± SE; n =15 animals. P values are the results of an unpaired Student’s t test. *P < 0.05 was considered significant. C: plasma insulin levels during insulin tolerance tests performed at baseline and following 5–7 days of 0.1 M NH4Cl treatment. Data are means ± SE; n =15 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. D: the blood glucose response to glucose (1 g/kg) at baseline and following 5–7 days of 0.1 M NH4Cl. y-Axis, blood glucose (mg/dL); x-axis, time after glucose gavage (min). Data are means ± SE; n =5 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. E: AUC analysis for the blood glucose response to glucose. y-Axis, AUC; x-axis, testing time points (baseline and following NH4Cl treatment). Data are means ± SE; n =5 animals. P values are the results of an unpaired Student’s t test. *P < 0.05 was considered significant. F: plasma insulin levels during glucose tolerance tests performed at baseline and following 5−7 days of 0.1 M NH4Cl treatment. Data are means ± SE; n =5 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant.
Figure 4.
Figure 4.
Impact of renal mass reduction on insulin sensitivity prior to and following treatment with NH4Cl. A: the blood glucose response to insulin (0.75 U/kg) at baseline in sham rats and rats with 2/3 and 5/6 Nx nephrectomy (Nx). y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data are means ± SE; n =6 for sham, n =7 for 2/3 Nx, and n =8 for 5/6 Nx. 2/3 Nx rats in this study had a percent renal mass reduction of 60% < x <70%; 5/6 Nx rats in this study had a percent renal mass reduction of 70% ≤ x <85%. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. B: inverse area under the curve (AUC) analysis for the blood glucose response to insulin in Sham, 2/3 Nx, and 5/6 Nx rats at baseline. y-Axis, AUC; x-axis, level of Nx (sham, 2/3 Nx, and 5/6 Nx). Data are means ± SE; n =6 for sham, n =7 for 2/3 Nx, and n =8 for 5/6 Nx. P values are the results of one-way ANOVA. *P < 0.05 was considered significant. C: plasma insulin levels during a baseline insulin tolerance test in sham, 2/3 Nx, and 5/6 Nx rats. y-Axis, plasma insulin (ng/mL); x-axis, time after insulin injection (min). Data are means ± SE; n =6 for sham, n =7 for 2/3 Nx, and n =8 for 5/6 Nx. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. D: the blood glucose response to insulin (0.75 U/kg) prior to (baseline) and following 7 days of 0.1 M NH4Cl in 2/3 Nx rats. y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data are means ± SE; n =7 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. E: inverse AUC analysis for the blood glucose response to insulin in 2/3 Nx rats at baseline and following NH4Cl treatment. y-Axis, AUC; x-axis, testing time point (baseline and NH4Cl). Data are means ± SE; n =7 animals. P values are the results of a paired Student’s t test. *P < 0.05 was considered significant. F: the blood glucose response to insulin (0.75 U/kg) prior to (baseline) and following 5−7 days of 0.1 M NH4Cl in 5/6 Nx rats. y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data are means ± SE; n =8 animals. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. G: inverse AUC analysis for the blood glucose response to insulin in 5/6 Nx rats at baseline and following NH4Cl treatment. y-Axis, AUC; x-axis, testing time point (baseline and NH4Cl). Data are means ± SE; n =8 animals. P values are the results of a paired Student’s t test. *P < 0.05 was considered significant.
Figure 5.
Figure 5.
Impact of renal mass reduction on insulin sensitivity before and after treatment with NH4Cl in Zucker obese rats. A: the blood glucose response to insulin (0.75 U/kg) at baseline in sham and 5/6 nephrectomized (Nx) rats as well as 5/6 Nx rats following 4 days of 0.1 M NH4Cl. y-Axis, blood glucose (mg/dL); x-axis, time after insulin injection (min). Data are means ± SE; n =3 for sham and n =4 for 5/6 Nx. P values are the results of two-way ANOVA. *P < 0.05 was considered significant. B: inverse area under the curve (AUC) analysis for the blood glucose response to insulin in sham and 5/6 Nx rats at baseline and following NH4Cl treatment. y-Axis, AUC; x-axis, experimental groups (sham, 5/6 Nx baseline, and 5/6 Nx NH4Cl). Data are means ± SE; n =3 for sham and n =4 for 5/6 Nx. P values are the results of one-way ANOVA. *P < 0.05 was considered significant. C: plasma insulin levels during the insulin tolerance test at baseline in sham and 5/6 Nx rats and following NH4Cl in 5/6 Nx rats. y-Axis, plasma insulin (ng/mL); x-axis, time after insulin injection (min). Data are means ± SE; n =3 for sham and n =4 for 5/6 Nx. P values are the results of two-way ANOVA. *P < 0.05 was considered significant.
Figure 6.
Figure 6.
Relationship between insulin sensitivity and acid-base status in remnant kidney rats. A: relationship between pH and inverse area under the curve (AUC) throughout the study. y-Axis, inverse AUC analysis for the blood glucose response to insulin; x-axis, pH. Individual values from both Sprague Dawley and Zucker obese rats at all insulin tolerance test time points and blood gas measurements are shown. B: relationship between plasma HCO3 and inverse AUC throughout the study. y-Axis, inverse AUC analysis for the blood glucose response to insulin; x-axis, plasma HCO3 (mmol/L). Individual values from both Sprague Dawley and Zucker obese rats at all insulin tolerance test time points and blood gas measurements are shown. P values are the results of Deming (model II) linear regression. r indicates Pearson’s correlation. *P < 0.05 was considered significant.

References

    1. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53: 1343–1347, 1998. doi:10.1046/j.1523-1755.1998.00898.x. - DOI - PubMed
    1. Li Y, Zhang L, Gu Y, Hao C, Zhu T. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis. Perit Dial Int 33: 411–418, 2013. doi:10.3747/pdi.2012.00037. - DOI - PMC - PubMed
    1. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13: 1894–1900, 2002. doi:10.1097/01.asn.0000019900.87535.43. - DOI - PubMed
    1. Xu H, Huang X, Arnlöv J, Cederholm T, Stenvinkel P, Lindholm B, Risérus U, Carrero JJ. Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. Clin J Am Soc Nephrol 9: 690–697, 2014. doi:10.2215/CJN.05230513. - DOI - PMC - PubMed
    1. Gilbert RE, Mann JF, Hanefeld M, Spinas G, Bosch J, Yusuf S, Gerstein HC; The ORIGIN Trial Investigators. Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the outcome reduction with an initial glargine intervention (ORIGIN) trial. Diabetologia 57: 1325–1331, 2014. doi:10.1007/s00125-014-3238-4. - DOI - PubMed

Publication types